These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 9624543
21. Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. Periti P, Novelli A, Schildwachter G, Schmidt-Gayk H, Ryo Y, Zuck P. J Antimicrob Chemother; 1990 Dec; 26 Suppl E():63-9. PubMed ID: 2292532 [Abstract] [Full Text] [Related]
26. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. Gooch WM, Blair E, Puopolo A, Paster RZ, Schwartz RH, Miller HC, Smyre HL, Yetman R, Giguere GG, Collins JJ. Pediatr Infect Dis J; 1996 Feb; 15(2):157-64. PubMed ID: 8822290 [Abstract] [Full Text] [Related]
27. Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults. Namyslowski G, Misiolek M, Czecior E, Malafiej E, Orecka B, Namyslowski P, Misiolek H. J Chemother; 2002 Oct; 14(5):508-17. PubMed ID: 12462431 [Abstract] [Full Text] [Related]
28. Comparative clinical and microbiological study of amoxycillin-clavulanic acid and ciprofloxacin in acute purulent exacerbations of chronic bronchitis. Legnani D, Lombardo VM, Negretto GG, Beghi G, Caratozzolo O. J Hosp Infect; 1992 Nov; 22 Suppl A():69-74. PubMed ID: 1362752 [Abstract] [Full Text] [Related]
29. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group. O'Doherty B, Daniel R. Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290 [Abstract] [Full Text] [Related]
30. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome. Hoepelman IM, Möllers MJ, van Schie MH, Greefhorst AP, Schlösser NJ, Sinninghe Damsté EJ, van de Moosdijk CN, Dalinghaus WH, Eland ME, Mol SJ, Rozenberg-Arska M. Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709 [Abstract] [Full Text] [Related]
33. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis. Anzueto A, Fisher CL, Busman T, Olson CA. Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481 [Abstract] [Full Text] [Related]
34. A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis. Martinot JB, Carr WD, Cullen S, Heredia Budo JL, Bauer K, MacLeod C, Sanguinetti CM, van Veldhuizen WC, Clarithromycin Once-a-Day Study Group. Adv Ther; 2001 Jan; 18(1):1-11. PubMed ID: 11512528 [Abstract] [Full Text] [Related]
38. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group. Biebuyck XA. J Int Med Res; 1996 Jan; 24(5):407-18. PubMed ID: 8895044 [Abstract] [Full Text] [Related]